Silencing of NAMPT leads to up-regulation of insulin receptor substrate 1 gene expression in U87 glioma cells.

Tsymbal DO, Minchenko DO, Luzina OY, Riabovol OO, Danilovskyi SV, Minchenko OH

Open source

DOI
10.2478/enr-2020-0005
Published
2020 Jan 1
Container
Endocrine regulations
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2478/enr-2020-0005,
  title = {Silencing of NAMPT leads to up-regulation of insulin receptor substrate 1 gene expression in U87 glioma cells.},
  author = {Tsymbal DO and Minchenko DO and Luzina OY and Riabovol OO and Danilovskyi SV and Minchenko OH},
  year = {2020},
  journal = {Endocrine regulations},
  doi = {10.2478/enr-2020-0005},
  url = {https://doi.org/10.2478/enr-2020-0005}
}

RIS

TY  - JOUR
TI  - Silencing of NAMPT leads to up-regulation of insulin receptor substrate 1 gene expression in U87 glioma cells.
AU  - Tsymbal DO
AU  - Minchenko DO
AU  - Luzina OY
AU  - Riabovol OO
AU  - Danilovskyi SV
AU  - Minchenko OH
PY  - 2020
JO  - Endocrine regulations
DO  - 10.2478/enr-2020-0005
UR  - https://doi.org/10.2478/enr-2020-0005
ER  - 

APA

DO, T., DO, M., OY, L., OO, R., SV, D., & OH, M. (2020). Silencing of NAMPT leads to up-regulation of insulin receptor substrate 1 gene expression in U87 glioma cells.. Endocrine regulations. https://doi.org/10.2478/enr-2020-0005

Source records